Back

Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study

27 August 2023 (12:15 - 12:50)
Organised by: Logo
Congress Presentation Part of: The growing importance of phenotyping in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

5 More presentations in this session

Presentation thumbnail
Prognostic value of pulmonary hypertension in patients with advanced heart failure evaluated fort heart replacement therapy in the light of new definition of pulmonary hypertension.
Doctor A. Minervini (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Associations of fasting state glycemic biomarkers with mortality and morbidity in heart failure: Retrospective cohort study
Doctor K. Iwasaki (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Usefulness of a scoring evaluation for practical introduction of the guideline-directed medical therapy (GDMT) in heart failure patients
Doctor R. Matsukawa (Iizuka, JP)
Abstract Slides Video
Presentation thumbnail
Level of education and mortality in the vulnerable period following an acute heart failure hospitalization
Doctor G. Pereira Da Cunha (Curitiba, BR)
Abstract Slides Video
Presentation thumbnail
Red cell distribution width (RDW) to serum albumin ratio (RAR) in chronic heart failure
Doctor A. Toste (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
The growing importance of phenotyping in heart failure

The Event

Event poster

ESC Congress 2023

27 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Age- and sex-related trends in transthyretin amyloid cardiomyopathy prevalence in older patients with unexplained hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Comparative characteristics of patients with and without transthyretin amyloid cardiomyopathy in the TTRACK study population
thumbnail
Congress Presentation
Clinical red flags associated with transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: results of the TTRACK study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources